Investors

Insider Transactions

Date Name Sorted Ascending Title Type Shares Traded Price Range
Sep 20, 2011 goldstein joseph l Director Acquisition (Non Open Market) 10,000 n/a
Jul 1, 2011 goldstein joseph l Director Option Execute 10,000 28.81
Jul 1, 2011 goldstein joseph l Director Automatic Sell 10,000 55.91 - 56.40
May 4, 2011 goldstein joseph l Director Option Execute 5,000 28.81
May 4, 2011 goldstein joseph l Director Sell 5,000 48.89
Mar 21, 2011 goldstein joseph l Director Automatic Sell 11,505 40.00
Mar 9, 2011 goldstein joseph l Director Option Execute 15,000 9.17
Mar 9, 2011 goldstein joseph l Director Automatic Sell 3,495 39.35
Feb 11, 2011 goldstein joseph l Director Automatic Sell 2,761 36.66
Feb 10, 2011 goldstein joseph l Director Option Execute 5,000 15.80
Feb 10, 2011 goldstein joseph l Director Automatic Sell 2,239 35.27
Jan 27, 2011 goldstein joseph l Director Automatic Sell 5,401 34.67
Jan 26, 2011 goldstein joseph l Director Option Execute 10,000 15.80
Jan 26, 2011 goldstein joseph l Director Automatic Sell 4,599 34.35
Dec 17, 2010 goldstein joseph l Director Automatic Sell 5,281 32.00
Dec 16, 2010 goldstein joseph l Director Option Execute 10,000 15.01
Dec 16, 2010 goldstein joseph l Director Automatic Sell 4,719 31.80
Nov 24, 2010 goldstein joseph l Director Automatic Sell 4,331 30.06
Nov 23, 2010 goldstein joseph l Director Option Execute 10,000 15.01 - 18.80
Nov 23, 2010 goldstein joseph l Director Automatic Sell 5,669 29.81
Showing 301-320 of 920 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)